ask="N/A"
ask_size="N/A"
average_daily_volume="15846"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="+0.35"
change_from_200_day_moving_average="0.91"
change_from_50_day_moving_average="0.63"
change_from_52_week_high="-1.75"
change_From_52_week_low="3.10"
change_in_percent="+5.98%"
close="6.20"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.48"
eps_estimate_next_quarter="-0.11"
eps_estimate_next_year="-0.51"
ex_dividend_date="N/A"
float_shares="3450000"
high="6.65"
high_52_weeks="7.95"
last_trade_date="3/6/2017"
last_trade_price="6.20"
last_trade_size="126"
last_trade_time="4:00pm"
low="6.05"
low_52_weeks="3.10"
market_capitalization="178.00M"
moving_average_200_day="5.29"
moving_average_50_day="5.57"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="8.38"
open="6.45"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+17.21%"
percent_change_from_50_day_moving_average="+11.25%"
percent_change_from_52_week_high="-22.01%"
percent_change_from_52_week_low="+100.00%"
previous_close="5.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="13.24"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="2.98"
stock_exchange="ASE"
symbol="OCX"
volume="56627"
weeks_range_52="3.10 - 7.95"
